Category

News
Our director Marcelo Ribeiro was featured as one of the enterprising innovators from the University of Twente. Read the interview here!
Read More
Together with IamFluidics, Scinus Cell Expansion and the University of Twente, we received a €1 million subsidy from EFRO (Europees Fonds voor Regionale Ontwikkeling) OP Oost, in order to develop an efficient method of culturing human induced pluripotent stem cells (hiPSC) using microcarriers. We are proud to be part of this innovative initiative!
Read More
We are ready for Take-off! 🚀Today we received the €250,000 Take-off phase 2 subsidy from NWO (Dutch Research Council) to accelerate our product development.
Read More
We are delighted to announce that River BioMedics closed a successful deal with the University of Twente to spin-off! We are grateful for the collaboration and outstanding support of the University of Twente and especially the Novel-T team.
Read More
We are very excited to participate in the LIP@HEART project granted by Health~Holland to develop a heart-on-chip model using our 3D cardiac platform to facilitate identification of lipoprotein lipase-activating compounds! Result of a great collaboration with the Leiden University Medical Center and University of Twente.
Read More
Our project “Human mini-heart to improve drug discovery and development” was one out of the six projects in the Life Sciences field that received this grant to perform a feasibility study. 
Read More
River BioMedics was selected to pitch on the main stage in the plenary afternoon program of Innovation for Health in Rotterdam.
Read More
As part of the Health~Holland Venture Challenge Marcelo Ribeiro presented our company in a one-minute pitch. 
Read More
Robert Passier wrote a blog for the Dutch foundation “Proefdiervrij” about starting-up a company as a scientist.   
Read More
Each year the LifeSciences@Work accelerator for high potential startups organizes the Venture Challenge, a 10-week business development program that helps start-ups to develop their business case.
Read More
1 2